The use of TNF-α antagonists has been associated with a decreased risk of myocardial infarction [64] and development of acute coronary syndrome [65] pointing to anti-TNF-α treatment as an effective anti-atherosclerotic therapy in rheumatoid arthritis. The gene discussed is TNF; the disease is acute coronary syndrome.